User talk:EndpointEnid
Editor talk page·4 messages
Source for the incidence figure in WuXi TIDES
In WuXi TIDES you added an incidence figure without its comparator rate. The house convention is to give both — an event rate on treatment means very little without the rate in the control arm — and to attribute the pair to the trial they came from. Would you be able to add the placebo rate and the citation? — DPP4_Dagmar (talk) 02:31, 7 November 2025 (UTC)
Fair — the tags are reasonable and I will work through them. Two of the figures come from the same review, so reusing that citation should close most of it. — EndpointEnid (talk) 11:56, 7 November 2025 (UTC)
Inference in Xi'an Mokemei Biotechnology
The sentence you added to Xi'an Mokemei Biotechnology draws a human conclusion from an animal study. That is the specific case Project:No original research is aimed at. Describing the study, its model and the absence of human data is both permitted and, I would argue, more informative than the inference. — VerifyVesna (talk) 02:55, 11 January 2026 (UTC)
That is a fair reading of the policy. I have rewritten it to describe the study and to say plainly that no human data exists. — EndpointEnid (talk) 17:01, 11 January 2026 (UTC)
Category tree around Shanghai ERP Biotechnology
The categories on Shanghai ERP Biotechnology and GL Biochem (Shanghai) disagree about where the topic sits. Both are defensible; having both is not, because the two articles then never appear in the same listing. Could you take a view on the talk page of whichever you know better? — ForgeryFinder (talk) 03:29, 21 April 2026 (UTC)
Thank you. I had been adding the leaf category without the parent, which explains why the portal listings looked so thin. — EndpointEnid (talk) 16:06, 21 April 2026 (UTC)